Accolade, Inc. (ACCD)
| Market Cap | 575.59M |
| Revenue (ttm) | 446.72M +15.0% |
| Net Income | -180.30M |
| EPS | -2.31 |
| Shares Out | 81.99M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,585,688 |
| Open | 7.03 |
| Previous Close | 7.03 |
| Day's Range | 7.01 - 7.03 |
| 52-Week Range | 3.08 - 9.67 |
| Beta | 2.10 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Apr 24, 2025 |
About ACCD
Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management speci... [Read more]
Financial Performance
In 2023, Accolade's revenue was $414.29 million, an increase of 14.09% compared to the previous year's $363.14 million. Losses were -$99.81 million, -78.29% less than in 2022.
Financial StatementsNews
Vontier Earns Top Accolade at International Sustainability Awards
RALEIGH, N.C.--(BUSINESS WIRE)--Vontier (NYSE: VNT), a leading global provider of critical technologies and solutions to connect, manage and scale the mobility ecosystem, today announced it won Gold a...
Scripps Cancer Center Leader Receives National Accolade
American Radium Society Honors Thomas Buchholz, M.D., with 2026 Gold Medal Award American Radium Society Honors Thomas Buchholz, M.D., with 2026 Gold Medal Award
CoinEx Wins Top Accolade for Cryptocurrency Exchange at International Business Magazine Awards 2025
HONG KONG, Jan. 23, 2026 (GLOBE NEWSWIRE) -- CoinEx has been recognized by International Business Magazine with one of the highest honors in the cryptocurrency exchange sector, receiving the title “Be...
TalkingParents Takes Home 11th Accolade For Support Network Initiative
Fort Walton Beach, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The TalkingParents team earned its 11th award since 2022 when it was recognized for meeting the Florida Public Relations Association standard of ex...
The One Show Announces Historic Win: Klick Health Becomes First Health Agency to Ever Receive An Agency of the Year Accolade
NEW YORK & TORONTO--(BUSINESS WIRE)-- #Advertising--Klick Health is capping off The One Club's Creative Week tonight with a groundbreaking win, becoming the first health agency in The One Show's 52-ye...
Wellspring Launches Next-Gen Innovation Platform, Accolade Core
Accolade Core and the Core Six Framework Give Innovation Leaders the Tools to Deliver Measurable Business Growth Accolade Core and the Core Six Framework Give Innovation Leaders the Tools to Deliver M...
Pernod completes sale of wine portfolio to Accolade Wines owner
Pernod Ricard has completed the sale of its international wine portfolio, including brands like Jacob's Creek, to Accolade Wines owner Australian Wine Holdco, it said on Wednesday.
Digital health startup Transcarent takes Accolade private in $621 million deal
Transcarent on Tuesday announced it has completed its $621 million acquisition of Accolade. Accolade shareholders received $7.03 per share in cash, and the company will no longer be listed on the Nasd...
Transcarent Completes Merger With Accolade
SAN FRANCISCO & SEATTLE--(BUSINESS WIRE)-- #HealthWayFinding--Today Transcarent announced the successful completion of its merger with Accolade, the leading health advocacy, expert medical opinion, an...
Accolade Stockholders Approve Merger Between Accolade and Transcarent
SEATTLE, March 27, 2025 (GLOBE NEWSWIRE) -- Accolade (NASDAQ:ACCD) announced that Accolade stockholders voted to approve the merger with Transcarent at the Accolade special meeting of stockholders (th...
Accolade Welcomes Oshi Health to Trusted Partner Ecosystem
Partnership increases access to specialized, whole-person clinical care for people managing digestive health conditions SEATTLE , March 6, 2025 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) has partne...
Transcarent and Accolade Announce Expiration of Hart-Scott Rodino Waiting Period for Pending Merger Transaction
SAN FRANCISCO and SEATTLE, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Transcarent, the One Place for Health and Care, and Accolade (NASDAQ:ACCD), a leader in health advocacy, expert medical opinions, and prima...
Accolade Expands Virtual Care to Medicare Beneficiaries Nationwide Through PlushCare Direct-to-Consumer Offering
Effort broadens healthcare access and removes barriers to primary care and weight management services SEATTLE , Feb. 4, 2025 /PRNewswire/ -- Today, Accolade, Inc. (NASDAQ: ACCD) announced that its dir...
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Accolade
NEW YORK , Jan. 10, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Accolade (NASDAQ: ACCD) and its board of directors concerning the proposed acquisition ...
ACCOLADE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Accolade, Inc. - ACCD
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Accolade, Inc. (...
Healthcare M&A: Transcarent paying $621M to acquire Seattle-based health benefits firm Accolade
Seattle-based Accolade is set to go private again in a deal to be acquired by Transcarent that brings together two health benefits companies.
Transcarent To Acquire Accolade
SAN FRANCISCO & SEATTLE--(BUSINESS WIRE)-- #HealthWayFinding--Transcarent, the One Place for Health and Care, and Accolade (NASDAQ:ACCD), a leader in health advocacy, expert medical opinions, and prim...
Accolade to Announce Fiscal Third Quarter 2025 Financial Results
SEATTLE, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal third quarter 2025 financial results on Thursday, January 9, 2024 after the market ...
Accolade To Present at Upcoming Investor Conferences
SEATTLE, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor events. A webcast will be available at ir.accolad...
Porter Airlines Receives Another Accolade with APEX Four Star Major Airline Rating
TORONTO--(BUSINESS WIRE)--Porter Airlines has been rated a 2025 Four Star Major Airline by passengers, certified by the Airline Passenger Experience Association (APEX). The APEX Five Star and Four Sta...
Accolade Welcomes Renalogic to Trusted Partner Ecosystem
Partnership will drive cost savings for customers while providing high-touch services that improve health outcomes to members with chronic kidney disease (CKD). SEATTLE , Oct. 15, 2024 /PRNewswire/ -...
Accolade Inc (ACCD) Q2 Earnings: Revenue Hits $106.4M, Beating Estimates; GAAP EPS Loss at $0.30
On October 8, 2024, Accolade Inc (ACCD, Financial) released its 8-K filing detailing the financial results for the fiscal second quarter ending August 31, 2024. Accolade Inc, a company offering techno...
Accolade Announces Results for Fiscal Second Quarter 2025
SEATTLE, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2024.
Accolade Inc (ACCD) Q2 2025: Everything You Need to Know Ahead of Earnings
Accolade Inc (ACCD, Financial) is set to release its Q2 2025 earnings on Oct 8, 2024. The consensus estimate for Q2 2025 revenue is $105.01 million, and the earnings are expected to come in at -$0.44 ...
Accolade to Announce Fiscal Second Quarter 2025 Financial Results
SEATTLE, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal second quarter 2025 financial results on Tuesday, October 8, 2024 before market op...